3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Femoral Fractures: new trials by email Literature Review of Femoral Fractures trials Research Report on Femoral Fractures
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures Liposomal Bupivacaine, Ropivacaine HCL - Femoral Fractures | Phase 2 | Terminated | Ian Elliott Brown | 3 | 2017-10-01 | 2021-02-21 |
| Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032) MK0677 - Hip Fracture | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 83 | 2005-09-01 | 2016-01-20 |
| Image Guided System for Orthopaedic Surgery Image-guided surgical system - Orthopaedic Trauma, Hip Fracture | Phase 2 | Terminated | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 40 | 2002-12-01 | 2009-04-09 |
Hip Fractures (3) · Wounds and Injuries (1)
Fractures, Bone (3) · Hip Injuries (3) · Leg Injuries (3) · Wounds and Injuries (2)
Ropivacaine (1) · ibutamoren mesylate (1)
Ian Elliott Brown (1) · Merck Sharp & Dohme LLC (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)
United States (2) · Germany (1) · Norway (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Ian Brown, MD (1) · Thomas C. Kienzle, MD (1)